Recursion Pharmaceuticals, Inc. (RXRX) vs First Tracks Biotherapeutics, Inc. (TRAX)
- Recursion Pharmaceuticals, Inc. RXRX 3.57 +0.56%
- First Tracks Biotherapeutics, Inc. TRAX 50.27 −3.94%
Recursion Pharmaceuticals, Inc. and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Recursion Pharmaceuticals, Inc. and First Tracks Biotherapeutics, Inc. are of similar size ($2.2B and $2.2B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −697.1%) and the higher return on invested capital (0.00% vs −88.5%). Across the 11 metrics below, First Tracks Biotherapeutics, Inc. leads on 10 and Recursion Pharmaceuticals, Inc. on 1.
Valuation
Profitability
| Metric | RXRX | TRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 29.21% | — | 68.81% |
| Operating margin | (725.44%) | 0.00% | 0.00% |
| Net margin | (697.13%) | 0.00% | 0.00% |
| Free cash flow margin | (460.89%) | 0.00% | 0.00% |
| Return on equity | (48.72%) | 0.00% | (50.30%) |
| Return on assets | (36.29%) | 0.00% | (45.47%) |
| Return on invested capital | (88.54%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack